Annexon Inc (ANNX) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Annexon Inc   (NASDAQ: ANNX)


Annexon Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Annexon Inc's ROI in the second quarter of 2026?
Annexon Inc recorded a cumulative net loss of $-203 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -94.81%.

Within the Healthcare sector 617 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 4013, from total ROI ranking in the first quarter of 2026 at 4670.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -27.03 % -34.81 % -32.71 % -24.26 % 2.22 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 208 227 235 186 224
Return On Investment (TTM) -94.81 % -91.04 % -91.28 % -83.68 % -64.45 %
ANNX's Overall Ranking # 4013 # 4670 # 4092 # 4013 # 3904
Seq. Investment Change TTM -1.88 % -4.65 % -8.47 % -14.78 % -12.34 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -203 -198 -209 -209 -189




Return On Investment ANNX's Ranking
Within: No.
Industry # 279
Sector # 618
Overall # 4013

Return On Investment Statistics
High Average Low
-28.9 %
-54.9 %
-94.81 %
(Mar 31 2021)   (Jun 30 2026)







Financial Statements
Annexon Inc's II. Quarter Investments $ 208 Millions ANNX's Balance sheet
Annexon Inc's II. Quarter Income $ -55 Millions Quarterly ANNX's Income Statement
ANNX's Income by Division See ANNX's Income by Division


ANNX Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 235 320 280 263 265
Y / Y Investment Growth -26.48 % 14.23 % 6.47 % -0.96 % -23.17 %
Net Income in Millions -209 -138 -134 -142 -130
Y / Y Net Income Growth - - - - -
Annual Return On Investment -88.77 % -43.25 % -47.99 % -54.03 % -49.12 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ANNX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ANNX's Competitors
Subscribers only: Roi for Annexon Inc's Suppliers
Subscribers only: Return On Investment for ANNX's Customers

Other Ratios
ANNX's Roa ANNX's Inventory Turnover Ratio ANNX's Growth Rates ANNX's Dividend Statistics
ANNX's Profitability Ratios ANNX's Asset Turnover Ratio ANNX's Dividend Growth
ANNX's Roe ANNX's Valuation Ratios ANNX's Financial Strength Ratios ANNX's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI


Date modified: 2026-09-04T10:00:26+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.